Literature DB >> 30926147

Relation of Acute Decompensated Heart Failure to Silent Cerebral Infarcts in Patients With Reduced Left Ventricular Ejection Fraction.

Nil Ozyuncu1, Sadi Gulec2, Cansin Tulunay Kaya2, Huseyin Goksuluk2, Turkan Seda Tan2, Veysel Kutay Vurgun2, Ebru Us3, Cetin Erol2.   

Abstract

Heart failure (HF) is a prothrombotic state with increased rate of thromboembolic events. Magnetic resonance imaging studies demonstrated increased rate of silent cerebral infarcts (SCI) in this patient group and SCIs were shown lead to dementia, cognitive decline, and depression. We aimed to show acute decompensated phase is associated with increased rate of recent SCI in reduced ejection fraction HF patients. HF patients with sinus rhythm hospitalized for acute decompensation were studied. Neuron specific enolase (NSE), a sensitive neuronal ischemia marker, was used to detect recent SCI. Decompensated and compensated phase blood samples for NSE were collected on the day of admission and on the third day of compensation, respectively. One hundred and forty seven patients with mean age of 72 were studied. There were significantly more patients with positive NSE levels at decompensated state (29% vs 4%, p <0.001). Multivariate predictors for recent SCI were smoking, new onset atrial fibrillation, spontaneous echo contrast of left ventricle, and aneurysmatic apex. Statin use was found to be protective against NSE elevation. In conclusion, our data reveal that decompensated HF is significantly associated with increased levels of NSE suggestive for silent neuronal injury.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30926147     DOI: 10.1016/j.amjcard.2019.02.055

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Relationship between silent cerebral infarcts and quality of anticoagulation in patients with prosthetic mitral valves.

Authors:  Nil Özyüncü; Sadi Güleç; Hüseyin Göksülük; Kerim Esenboğa; Eralp Tutar
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

2.  Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure.

Authors:  Yangyang Jiang; Lei Wang; Ziwen Lu; Shiqi Chen; Yu Teng; Tong Li; Yang Li; Yingzhen Xie; Mingjing Zhao
Journal:  Front Cardiovasc Med       Date:  2022-01-26

3.  Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure.

Authors:  Takeru Nabeta; Keisuke Kida; Miwa Ishida; Takaaki Shiono; Norio Suzuki; Shunichi Doi; Maya Tsukahara; Yuki Ohta; Tetsuya Kimura; Keita Yamaguchi; Atsushi Takita; Naoki Matsumoto; Yoshihiro J Akashi; Junya Ako; Takayuki Inomata
Journal:  Clin Pharmacokinet       Date:  2021-03-30       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.